Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Trends Immunol. 2013 Mar 15;34(6):10.1016/j.it.2013.02.004. doi: 10.1016/j.it.2013.02.004

Table 1.

Animal models of Ras/ERK signaling in T cell development and function

Mouse model Developmental effect Refs
Grb2+/−
  • Normal positive selection

  • Defective negative selection

[46]
Grb2(T)−/−
  • Defective positive selection

  • Defective negative selection

[51]
Rasgrp1−/−
  • 20% reduction in thymocyte cellularity

  • Mild defect in β selection, but normal α-CD3ε induced proliferation in Rag2−/−

  • Defective positive selection

  • Normal negative selection

[16,26,27,34,38]
Rasgrp4−/−
  • Normal T cell development

[38]
Rasgrp1/Rasgrp4 DKO
  • 80% reduction in thymocyte cellularity

  • Defective βselection

  • Possible defect in positive selection (more than RasGRP1−/−) due to further reduction in peripheral T cell numbers

  • Negative selection not examined

[38]
Sos1(T)−/−
  • 50% reduction in thymocyte cellularity

  • Proliferative defect at β-selection checkpoint/defective α-CD3ε-induced proliferation in Rag2−/−

  • Normal positive and negative selection

[26,27]
Sos2−/−
  • Normal T cell development, did not modulate Sos1 or RasGRP1 knockout phenotype

[27]
Sos1(T)/Rasgrp1 DKO
  • 70–90% reduction in thymocyte cellularity

  • Defective βselection

  • Defective positive and negative selection

[27]
Rasgrf2−/−
  • Normal T cell development

[37]
Rasa1−/− (p120RasGAP deficient)
  • Normal β-selection

  • Enhanced MHC class II-mediated positive selection

  • Normal negative selection

  • Reduced IL-7-mediated survival of naïve peripheral CD4+ and CD8+ lymphocytes

[71]
Nras−/−
  • Normal positive and negative selection

  • Reduced antiviral responses

  • Impaired TH1 differentiation/INFγ responses

[72,73]
Hras−/−
  • Normal positive and negative selection

  • Impaired TH1 differentiation/INFγ responses

[72]
Mapk3−/− (ERK1 deficient)
  • Normal β selection

  • Mild defect in positive selection

  • Normal negative selection

[7,9]
Mapk1−/− (ERK2 deficient)
  • 50% reduction in thymocyte cellularity

  • Defective β selection

  • Defective positive selection, negative selection not tested

  • Impaired TH1 differentiation

  • Impaired T cell proliferation and survival

[7,74,75]
Mapk3/Mapk1 DKO (ERK1 and ERK2 deficient)
  • 75% reduction in thymocyte cellularity

  • Defective β selection

  • Defective positive selection

  • Normal negative selection

[7,47]
Lat-Y136F
  • Defective β selection

  • Defective positive and negative selection

  • Develop an ERK-dependent TH2 lymphoproliferative disease dependent, in part, on signaling via Bam32, RasGRP1, and Sos1/2

[11,12,54,55]

INF, interferon.